Multifaceted approach to treatment of acute respiratory viral infections

According to the World Health Organization, acute respiratory viral infections (ARVIs) account for 70–85% of all cases of infectious diseases in the world. High prevalence rates of ARVIs, influenza and COVID-19 require the search for new methods to prevent, treat, and control epidemics. Furthermore, there are significant economic losses due to high incidence and temporary disability rates. ARVIs constitute a heterogenous group of the infectious respiratory tract disorders caused by numerous viruses, such as influenza virus, parainfluenza virus, respiratory syncytial virus, adenovirus, coronavirus, and many other viruses. Symptoms of various ARVIs have much in common and include fever, cough, chest pain, headache, myalgia, asthenia, anosmia, etc. The paper discusses the features of diagnostic search and treatment tactics in seasonal ARVIs, as well as feasibility of preventive measures. The data of meta-analyses and systematic reviews are used to explore the role and potential of zinc, selenium, vitamin C, vitamin A, and vitamin E for prevention and treatment of bronchopulmonary diseases in adults. © 2023, LLC MMA MediaMedika. All rights reserved.